Cambridge Investment Research Advisors’s BondBloxx Bloomberg Seven Year Target Duration US Treasury ETF XSVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Buy
24,924
+3,940
+19% +$186K ﹤0.01% 2148
2026
Q1
$1M Buy
20,984
+2,510
+14% +$121K ﹤0.01% 2165
2025
Q4
$888K Buy
18,474
+3,729
+25% +$180K ﹤0.01% 2195
2025
Q3
$710K Buy
14,745
+3,562
+32% +$170K ﹤0.01% 2340
2025
Q2
$535K Buy
+11,183
New +$529K ﹤0.01% 2484

Other funds holding XSVN

Cambridge Investment Research Advisors's XSVN Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its BondBloxx Bloomberg Seven Year Target Duration US Treasury ETF (XSVN) stake by 19% in Q2 2026, buying an estimated $186K and bringing the position to 24,924 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #2148.

Cambridge Investment Research Advisors first reported a position in XSVN in Q2 2025 and has held it in 5 quarters since. 24 funds tracked by Wall St. Rank hold XSVN as of Q2 2026.

  • Cambridge Investment Research Advisors held 24,924 shares of BondBloxx Bloomberg Seven Year Target Duration US Treasury ETF worth $1.18M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 3,940 BondBloxx Bloomberg Seven Year Target Duration US Treasury ETF shares in Q2 2026, an estimated $186K.
  • BondBloxx Bloomberg Seven Year Target Duration US Treasury ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2148 holding.
  • Cambridge Investment Research Advisors first reported a position in BondBloxx Bloomberg Seven Year Target Duration US Treasury ETF in Q2 2025 and has held it in 5 quarters since.
  • 24 funds tracked by Wall St. Rank held BondBloxx Bloomberg Seven Year Target Duration US Treasury ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.